Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd (SHE:002864)
35.38
+0.03 (0.08%)
Feb 4, 2026, 3:04 PM CST
SHE:002864 Revenue
Shaanxi Panlong Pharmaceutical Group Limited By Share had revenue of 267.43M CNY in the quarter ending September 30, 2025, with 2.24% growth. This brings the company's revenue in the last twelve months to 1.10B, up 11.91% year-over-year. In the year 2024, Shaanxi Panlong Pharmaceutical Group Limited By Share had annual revenue of 973.86M, down -0.71%.
Revenue (ttm)
1.10B
Revenue Growth
+11.91%
P/S Ratio
3.41
Revenue / Employee
1.18M
Employees
933
Market Cap
3.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 973.86M | -6.96M | -0.71% |
| Dec 31, 2023 | 980.83M | 6.53M | 0.67% |
| Jan 1, 2023 | 974.29M | 86.81M | 9.78% |
| Jan 1, 2022 | 887.48M | 217.17M | 32.40% |
| Dec 31, 2020 | 670.31M | 59.68M | 9.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.79B |
| PKU HealthCare Corp.,Ltd. | 1.76B |
| Nanjing Well Pharmaceutical Group | 1.31B |
| Huaren Pharmaceutical | 1.26B |
| Anhui Sunhere Pharmaceutical Excipients | 934.72M |
| Harbin Medisan Pharmaceutical | 874.60M |
| Zhejiang Shengda Bio-Pharm | 839.82M |
| Zhejiang Cheng Yi Pharmaceutical | 790.86M |